Mirador Capital Partners’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-63,479
| Closed | -$608K | – | 195 |
|
|
2022
Q3 | $608K | Sell |
63,479
-1,211
| -2% | -$11.6K | 0.15% | 93 |
|
|
2022
Q2 | $714K | Buy |
64,690
+21,585
| +50% | +$238K | 0.17% | 93 |
|
|
2022
Q1 | $718K | Buy |
43,105
+3,039
| +8% | +$50.6K | 0.15% | 103 |
|
|
2021
Q4 | $765K | Buy |
40,066
+14,772
| +58% | +$282K | 0.16% | 104 |
|
|
2021
Q3 | $624K | Buy |
25,294
+1,036
| +4% | +$25.6K | 0.14% | 120 |
|
|
2021
Q2 | $631K | Buy |
+24,258
| New | +$631K | 0.14% | 119 |
|